UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009

The lancet oncology, 2009-11, Vol.10 (11), p.1111-1118

2009

Volltextzugriff (PDF)

Coffee, alcohol and other beverages in relation to cirrhosis mortality: The Singapore Chinese Health Study

Hepatology (Baltimore, Md.), 2014-08, Vol.60 (2), p.661-669

2014

Volltextzugriff (PDF)

Peginterferon Alfa-2a, Lamivudine, and the Combination for HBeAg-Positive Chronic Hepatitis B

The New England journal of medicine, 2005-06, Vol.352 (26), p.2682-2695

2005

Volltextzugriff (PDF)

Association between diabetes mellitus and cirrhosis mortality: the Singapore Chinese Health Study

Liver international, 2017-02, Vol.37 (2), p.251-258

2017

Volltextzugriff (PDF)

HBeAg and hepatitis B virus DNA as outcome predictors during therapy with peginterferon alfa‐2a for HBeAg‐positive chronic hepatitis B

Hepatology (Baltimore, Md.), 2008-02, Vol.47 (2), p.428-434

2008

Volltextzugriff (PDF)

No association between IFNL3 (IL28B) genotype and response to peginterferon alfa-2a in HBeAg-positive or -negative chronic hepatitis B

PloS one, 2018-07, Vol.13 (7), p.e0199198-e0199198

2018

Volltextzugriff (PDF)

Editorial: Interaction of endocrine disorders and metabolic associated fatty liver disease: the genetic and epigenetic basis

Frontiers in endocrinology (Lausanne), 2023, Vol.14, p.1308860-1308860

2023

Volltextzugriff (PDF)

Towards health market systems changes for migrant workers based on the COVID-19 experience in Singapore

BMJ global health, 2020-09, Vol.5 (9), p.e003054

2020

Volltextzugriff (PDF)

Virtual monitoring for stable chronic hepatitis B patients does not reduce adherence to medications: A randomised controlled study

Journal of telemedicine and telecare, 2023-05, Vol.29 (4), p.261-270

2023

Volltextzugriff (PDF)

Reponse to the association between diabetes mellitus and cirrhosis mortality

Liver international, 2017-03, Vol.37 (3), p.467-467

2017

Volltextzugriff (PDF)

Immunosuppressive Drug‐Resistant Armored T‐Cell Receptor T Cells for Immune Therapy of HCC in Liver Transplant Patients

Hepatology (Baltimore, Md.), 2021-07, Vol.74 (1), p.200-213

2021

Volltextzugriff (PDF)

Fructose intake in patients with non-alcoholic fatty liver disease

Proceedings of Singapore healthcare, 2019-12, Vol.28 (4), p.218-223

2019

Volltextzugriff (PDF)

Comparing the safety, tolerability and quality of life in patients with chronic hepatitis B vs chronic hepatitis C treated with peginterferon alpha-2a

Liver international, 2008-04, Vol.28 (4), p.477-485

2008

Volltextzugriff (PDF)

Chronic hepatitis B virus (HBV) infection in pregnancy

Hepatology international, 2008-09, Vol.2 (3), p.370-375

2008

Volltextzugriff (PDF)

Unhealthy lifestyle habits and physical inactivity among Asian patients with non‐alcoholic fatty liver disease

Liver international, 2020-11, Vol.40 (11), p.2719-2731

2020

Volltextzugriff (PDF)

Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease

The New England journal of medicine, 2004-10, Vol.351 (15), p.1521-1531

2004

Volltextzugriff (PDF)

Suboptimal treatment of dyslipidemia in patients with nonalcoholic fatty liver disease

Journal of gastroenterology and hepatology, 2020-02, Vol.35 (2), p.320-325

2020

Volltextzugriff (PDF)

Clinical profile of non‐alcoholic fatty liver disease in nonobese patients

Journal of gastroenterology and hepatology, 2021-01, Vol.36 (1), p.257-261

2021

Volltextzugriff (PDF)

Inflammasome-Driven Fatal Acute-on-Chronic Liver Failure Triggered by Mild COVID-19

Viruses, 2024-10, Vol.16 (10), p.1646

2024

Volltextzugriff (PDF)

Hepatic steatosis and metabolic risk factors among patients with chronic hepatitis B: The multicentre, prospective CAP‐Asia study

Journal of viral hepatitis, 2023-04, Vol.30 (4), p.319-326

2023

Volltextzugriff (PDF)

Validation of the Expanded Baveno-VI Criteria for Screening Gastroscopy in Asian Patients with Compensated Advanced Chronic Liver Disease

Digestive diseases and sciences, 2021-04, Vol.66 (4), p.1343-1348

2021

Volltextzugriff (PDF)

The utility of non‐invasive tests to assess advanced fibrosis in Asian subjects with chronic hepatitis B and concomitant hepatic steatosis

Liver international, 2023-05, Vol.43 (5), p.1008-1014

2023

Volltextzugriff (PDF)

Prevalence and risk factors for impaired renal function among Asian patients with nonalcoholic fatty liver disease

Hepatobiliary & pancreatic diseases international, 2024-06, Vol.23 (3), p.241-248

2024

Volltextzugriff (PDF)

Clinical and economic evaluation of a surveillance protocol to manage hepatitis B virus (HBV) reactivation among lymphoma patients with resolved HBV infection receiving rituximab

Pharmacotherapy, 2021-04, Vol.41 (4), p.332-341

2021

Volltextzugriff (PDF)

1 – 25 von 156

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(147)
Mit Volltextzugriff
(141)

Publikationsform

Sprache

Englisch
(156)

Erscheinungsjahr

n.n

Thema

Science & Technology
(112)
Life Sciences & Biomedicine
(90)
Humans
(74)
Female
(43)
Male
(41)
Middle Aged
(39)
Adult
(33)
Gastroenterology & Hepatology
(28)
Aged
(22)
Hepatitis
(20)
Hepatitis B
(17)
Oncology
(17)
Risk Factors
(17)
General & Internal Medicine
(15)
Medicine, General & Internal
(14)
Science & Technology - Other Topics
(14)
Multidisciplinary Sciences
(13)
Patients
(13)
Antiviral Agents - Therapeutic Use
(12)
Biological And Medical Sciences
(12)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009

Coffee, alcohol and other beverages in relation to cirrhosis mortality: The Singapore Chinese Health Study

Peginterferon Alfa-2a, Lamivudine, and the Combination for HBeAg-Positive Chronic Hepatitis B

Association between diabetes mellitus and cirrhosis mortality: the Singapore Chinese Health Study

HBeAg and hepatitis B virus DNA as outcome predictors during therapy with peginterferon alfa‐2a for HBeAg‐positive chronic hepatitis B

No association between IFNL3 (IL28B) genotype and response to peginterferon alfa-2a in HBeAg-positive or -negative chronic hepatitis B

Editorial: Interaction of endocrine disorders and metabolic associated fatty liver disease: the genetic and epigenetic basis

Towards health market systems changes for migrant workers based on the COVID-19 experience in Singapore

Virtual monitoring for stable chronic hepatitis B patients does not reduce adherence to medications: A randomised controlled study

Reponse to the association between diabetes mellitus and cirrhosis mortality

Immunosuppressive Drug‐Resistant Armored T‐Cell Receptor T Cells for Immune Therapy of HCC in Liver Transplant Patients

Fructose intake in patients with non-alcoholic fatty liver disease

Comparing the safety, tolerability and quality of life in patients with chronic hepatitis B vs chronic hepatitis C treated with peginterferon alpha-2a

Severity of gastric intestinal metaplasia predicts the risk of gastric cancer: a prospective multicentre cohort study (GCEP)

Chronic hepatitis B virus (HBV) infection in pregnancy

Unhealthy lifestyle habits and physical inactivity among Asian patients with non‐alcoholic fatty liver disease

Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease

Suboptimal treatment of dyslipidemia in patients with nonalcoholic fatty liver disease

Clinical profile of non‐alcoholic fatty liver disease in nonobese patients

Inflammasome-Driven Fatal Acute-on-Chronic Liver Failure Triggered by Mild COVID-19

Hepatic steatosis and metabolic risk factors among patients with chronic hepatitis B: The multicentre, prospective CAP‐Asia study

Validation of the Expanded Baveno-VI Criteria for Screening Gastroscopy in Asian Patients with Compensated Advanced Chronic Liver Disease

The utility of non‐invasive tests to assess advanced fibrosis in Asian subjects with chronic hepatitis B and concomitant hepatic steatosis

Prevalence and risk factors for impaired renal function among Asian patients with nonalcoholic fatty liver disease

Clinical and economic evaluation of a surveillance protocol to manage hepatitis B virus (HBV) reactivation among lymphoma patients with resolved HBV infection receiving rituximab

Suchergebnisse filtern